Registry of all Projects in Switzerland (RAPS)

Registry database of all projects approved by the ethics committees in Switzerland

Lead EC
  •  Comitato etico cantonale Ticino
  •  Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD)
  •  Commission Cantonale d'éthique de la recherche Genève (CCER)
  •  Ethikkommission Nordwest- und Zentralschweiz EKNZ
  •  Ethikkommission Ostschweiz (EKOS)
  •  Kantonale Ethikkommission Bern
  •  Kantonale Ethikkommission Zürich
  • Apply
Type of project
  •  clinical trial
  •  deceased persons
  •  non clinical, involving persons
  •  personal data/biological material
  • Apply
Category
Study phase (clinical trials only)
  •  n/a
  •  phase 1
  •  phase 1/2
  •  phase 2
  •  phase 3
  •  phase 4
  • Apply
multi- / monocentric
Study Ended
Displaying 1 - 20 of 7066
BASEC ID Project title Type of project Category Study phase (clinical trials only) Principal investigator Sponsor multi- / monocentric Lead EC Local EC(s) Investigational sites Approval date Study Ended
2015-00155 The effect of intracoronary re-infusion of bone marrow-derived mononuclear cells (BM-MNC) on all cause mortality in acute Myocardial Infarction clinical trial C Prof Dr Tiziano Moccetti Queen Mary University London monocentric Comitato etico cantonale Ticino Cardiocentro Ticino, Lugano
Fondazione Cardiocentro Ticino, Lugano
24.02.2017
2015-00194 A multicenter, open-label, follow-up study to assess the long-term use of lacosamide (flexible dose from 200 to 600mg/day) used as monotherapy in subjects who completed SP0994 and received lacosamide More ... clinical trial B phase 3 Dr. Pamela Agazzi UCB Biopharma SPRL multicentric Comitato etico cantonale Ticino Kantonale Ethikkommission Bern Ethikkommission Nordwest- und Zentralschweiz EKNZ Ospedale Regionale die Lugano – Civico e Italiano, 6903 Lugano
Neurologie Centre hospitalier Bienne, Im Vogelsang 84, 2501 Bienne
Kantonsspital Aarau AG, 5001 Aarau
18.05.2016 Study has ended
2015-00232 Bioavailability and tolerability study of two new DHEP medicated plasters in comparison with the marketed DHEP medicated plaster 1.3% (Flector®) clinical trial C phase 1 Milko Radicioni, MD, Principal Investigator IBSA Institut Biochimique S.A. monocentric Comitato etico cantonale Ticino CROSS Research S.A., Arzo 08.02.2016 Study has ended
2016-00004 A Phase 2 Study to Evaluate the Efficacy and Tolerability of Debio 1562 in
Combination with Rituximab in Patients with Relapsed and/or Refractory
Diffuse Large B-Cell Lymphoma and Other Forms of Non- More ...
clinical trial C phase 2 Dr. Anastasios Stathis Debiopharm international S.A. monocentric Comitato etico cantonale Ticino Istituto Oncologico della Svizzera Italiana, Ospedale Regionale Bellinzona e Valli, Bellinzona 15.04.2016 Study has ended
2016-00015 Tako-Tsubo Cardiomyopathy and Cardiac Syndrome X: a study on the brain-heart interactions in two orphan cardiac diseases. (BRAINHEART study) non clinical, involving persons A Dr. med. Mattia Cattaneo monocentric Comitato etico cantonale Ticino Division of Cardiovascular Research, Ospedale Regionale di Bellinzona e Valli - San Giovanni Hospital, CH - 6500 Bellinzona 29.03.2016
2016-00017 Extensibility of the hamstrings: comparison of passive stretching and treatment with Roller-Massager. clinical trial A Marco Barbero monocentric Comitato etico cantonale Ticino SUPSI, Manno 11.02.2016 Study has ended
2016-00021 Perinatal depression: chronobiology, sleep related risk factor and light therapy clinical trial A Dr. med. Mauro Manconi monocentric Comitato etico cantonale Ticino Ospedale Regionale di Lugano, Lugano 31.05.2016
2016-00038 “Is PECS block equivalent to paravertebral block in preventing postoperative pain after breast surgery? A randomized,controlled, double-blind trial”. clinical trial A Dr Andrea Saporito Ospedale San Giovanni monocentric Comitato etico cantonale Ticino Ospedale San Giovanni, Bellinzona 11.01.2017
2016-00062 L’arresto cardiaco (AC) come trauma per il familiare: sintomatologia e possibili modelli di indagine, intervento e prevenzione non clinical, involving persons A Prof. Claudio Benvenuti monocentric Comitato etico cantonale Ticino Fondazione Cuore Ticino, Breganzona 21.07.2016
2016-00169 Does the range of motion of the cervical spine increase after mobilisation? A comparison of two Cyriax mobilisation techniques. clinical trial A Marco Barbero monocentric Comitato etico cantonale Ticino SUPSI, Manno 17.01.2017 Study has ended
2016-00171 Assessment of liver stiffness in HCV infected patients undergoing antiviral treatment with new DAA personal data/biological material Dr. med. Benedetta Terziroli Beretta-Piccoli Fondazione Epatocentro Ticino monocentric Comitato etico cantonale Ticino Epatocentro Ticino, Lugano 21.03.2016 Study has ended
2016-00192 PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, MULTICENTER STUDY TO COMPARE THE EFFICACY AND SAFETY OF LENALIDOMIDE (CC-5013) PLUS R-CHOP CHEMOTHERAPY (R2-CHOP) VERSUS PLACEBO PLUS R-CHOP CHEMO More ... clinical trial B phase 3 Dr Anastasios Stathis Celgene Corporation multicentric Comitato etico cantonale Ticino Ethikkommission Nordwest- und Zentralschweiz EKNZ Commission Cantonale d'éthique de la recherche Genève (CCER) Kantonale Ethikkommission Zürich Istituto Oncologico della Svizzera Italiana, Ospedale Regionale Bellinzona e Valli, Bellinzona
Hopitaux Universitaire de Geneve, Geneve
Kantonosspital Aarau AG, Aarau
12.12.2016
2016-00193 ART for AGES (AfA). The benefits of musical experience on the health and wellbeing of older adults in nursing homes: a clinical trial clinical trial A prof Paola Di Giulio monocentric Comitato etico cantonale Ticino SUPSI, Manno 10.03.2016
2016-00326 A Phase IB Dose Exploration Trial with MK-8628, a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal (BET) Proteins, in Subjects with Selected Advanced Solid Tumors clinical trial C phase 1/2 Anastasios Stathis Merck Sharp & Dohme Corp. Whitehouse Station, NJ (USA), a subsidiary of Merck & Co., Inc. Kenilworth, NJ (USA) monocentric Comitato etico cantonale Ticino Istituto Oncologico della Svizzera Italiana (IOSI), Bellizona 10.05.2016 Study has ended
2016-00327 MK-8628-005: A Phase IB Trial with MK-8628, a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal (BET) Proteins, in Subjects with Selected Hematologic Malignancies clinical trial C phase 1/2 Dr. med. Anastasios Stathis Merck Sharp & Dohme Corp. Whitehouse Station, NJ (USA), a subsidiary of Merck & Co., Inc. Kenilworth, NJ (USA) monocentric Comitato etico cantonale Ticino Istituto Oncologica della Svizzera Italiana, Bellinzona 23.05.2016 Study has ended
2016-00339 PROGETTO ALISA: IMPATTO DI DIETA E DIGIUNO IN DONNE CON CARCINOMA MAMMARIO: MIGLIORAMENTO DELLA TOLLERANZA AI TRATTAMENTI, DELLA QUALITÀ DI VITA E POSSIBILE IMPATTO SULLA PREVENZIONE DELLE RECIDIVE E More ... clinical trial A MD Olivia Pagani monocentric Comitato etico cantonale Ticino CSSI - IOSI, Lugano 04.08.2016
2016-00346 Bioavailability and tolerability study of two new diclofenac epolamine lecithin gel formulations (2.6% and 3.9%) in comparison with the marketed diclofenac epolamine lecithin gel formulation 1.3% (Eff More ... clinical trial C phase 1 Milko Radicioni, MD, Principal Investigator IBSA Institut Biochimique S.A. monocentric Comitato etico cantonale Ticino CROSS Research S.A., Arzo 07.04.2016
2016-00359 CLTT462X2101
A phase I dose finding study of oral LTT462 in adult patients with advanced solid tumors harboring MAPK pathway alterations
clinical trial C phase 1 Dr. med. Anastasios Stathis Novartis Pharma Schweiz AG multicentric Comitato etico cantonale Ticino Kantonale Ethikkommission Zürich IOSI, Bellinzona 23.05.2016
2016-00361 The development of collaborative palliative care integration in respiratory medicine consultations for adult outpatients with advanced chronic obstructive pulmonary disease (COPD): An action research More ... non clinical, involving persons A Dr. med. Tanja Fusi monocentric Comitato etico cantonale Ticino IOSI-EOC, 6500 Bellinzona 13.04.2016 Study has ended
2016-00365 A PHASE 3, MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY OF
AVELUMAB* (MSB0010718C) ALONE OR IN COMBINATION WITH
PEGYLATED LIPOSOMAL DOXORUBICIN VERSUS PEGYLATED LIPOSOMAL
DOXORUBICIN ALONE IN PATIENTS WI More ...
clinical trial C phase 3 Dr. Cristiana Sessa Pfizer, Inc. multicentric Comitato etico cantonale Ticino Ethikkommission Nordwest- und Zentralschweiz EKNZ Kantonale Ethikkommission Zürich Istituto Oncologico della Svizzera Italiana (IOSI)/Oncology Institute of Southern Switzerland, Ospedale San Giovanni, CH-6500 Bellinzona
Universitätsspital Basel, Frauenklinik, Abt. Gynäkologie/Gynäko More ...
16.08.2016 Study has ended